MIRA PHARMACEUTICALS, INC.
Clinical-stage pharma company developing therapies for neurologic/neuropsychiatric disorders.
MIRA | US
Overview
Corporate Details
- ISIN(s):
- US60458C1045
- LEI:
- Country:
- United States of America
- Address:
- 1200 BRICKELL AVENUE, 33131 MIAMI
- Website:
- https://mirapharmaceuticals.com/
- Sector:
- Manufacturing
Description
MIRA Pharmaceuticals, Inc. is a clinical-stage pharmaceutical development company focused on therapies for neurologic and neuropsychiatric disorders. The company's pipeline features two primary neuroscience programs. The first is Ketamir-2, an oral ketamine analog being developed for the treatment of pain and depression. The second is MIRA-55, a synthetic marijuana analog targeting anxiety and cognitive decline. MIRA aims to develop next-generation therapeutics that are safer, more accessible, and affordable for patients.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all MIRA PHARMACEUTICALS, INC. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for MIRA PHARMACEUTICALS, INC.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for MIRA PHARMACEUTICALS, INC. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
